secwatch.observer — SEC 8-K summary
======================================

Issuer:     Humacyte, Inc. (HUMA)
CIK:        0001818382
Form:       8-K
Filed at:   2024-09-25T23:59:59+00:00
Accession:  0001104659-24-102498
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Humacyte enters $50M equity purchase agreement with Lincoln Park Capital
------------------------------------------------------------------------

- Company can sell up to $50M of common stock to Lincoln Park over 24 months at its discretion.
- Purchase price is 97% of the lower of the daily low or average of three lowest closing prices over prior 10 days.
- Shares not sold below $1.00 floor price; maximum regular purchase of 100,000 shares or $1.5M per day.
- Commitment fee of 115,705 shares issued to Lincoln Park; net proceeds for R&D, commercial launch, and working capital.
- Lincoln Park agrees not to engage in short-selling or hedging during the term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818382/000110465924102498/0001104659-24-102498-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818382/000110465924102498/tm2424623d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-102498

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer